The FBN1 Gene Ectopia Lentis Familial Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the FBN1 gene, which are associated with familial ectopia lentis. Ectopia lentis is a condition characterized by the displacement or malposition of the eye's lens, which can lead to visual impairments. This condition is often hereditary and is linked to Marfan Syndrome and other connective tissue disorders, with the FBN1 gene playing a crucial role in the development of the body's connective tissues.
This genetic test is critical for individuals with a family history of ectopia lentis or related connective tissue disorders, as early identification of FBN1 gene mutations can facilitate timely intervention and management of the condition. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the FBN1 gene that are known to cause ectopia lentis.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test is conducted in a state-of-the-art laboratory setting by experienced geneticists and laboratory technicians, ensuring high accuracy and reliability of the results. By opting for this test, individuals can gain valuable insights into their genetic predisposition to ectopia lentis and related conditions, enabling them to make informed decisions about their health and future.
The ADAMTSL4 gene ectopia lentis isolated autosomal recessive genetic test is a specialized diagnostic procedure designed to identify mutations in the ADAMTSL4 gene, which are known to cause isolated ectopia lentis in an autosomal recessive manner. Ectopia lentis refers to the dislocation or displacement of the eye's lens, a condition that can significantly affect vision. When caused by mutations in the ADAMTSL4 gene, the condition does not typically present with other systemic features, distinguishing it from syndromic forms of ectopia lentis.
This genetic test involves analyzing the patient's DNA to detect mutations in the ADAMTSL4 gene that are responsible for the condition. Early detection through this test can aid in the management and treatment of ectopia lentis, helping to prevent potential complications and improve quality of life for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a reliable and accurate means of diagnosis for families concerned about this inheritable eye condition. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results. By choosing DNA Labs UAE for this test, patients can expect high-quality service and comprehensive support throughout the testing process.
The LOXL1 Gene Exfoliation Syndrome Susceptibility Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify genetic predispositions to exfoliation syndrome (XFS), a significant risk factor for glaucoma. This condition is characterized by the accumulation of extracellular fibrillar material in the eye, leading to increased intraocular pressure and potential vision loss. The LOXL1 gene has been identified as a critical factor in the development of XFS, making this test a crucial tool for early detection and management of the syndrome.
The test involves analyzing the patient's DNA to detect mutations in the LOXL1 gene that are associated with an increased risk of developing exfoliation syndrome. Early identification of these genetic markers can enable proactive monitoring and intervention, potentially preserving vision by preventing the progression to glaucoma.
Priced at 4400 AED, the LOXL1 Gene Exfoliation Syndrome Susceptibility Genetic Test is accessible at DNA Labs UAE, where cutting-edge technology and expertise ensure accurate and reliable results. Individuals with a family history of glaucoma or exfoliation syndrome, or those exhibiting early symptoms, may particularly benefit from this test, enabling them to take timely steps towards eye health management.
The FZD4 Gene Exudative Vitreoretinopathy Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the FZD4 gene, which are linked to the development of Familial Exudative Vitreoretinopathy (FEVR). FEVR is a hereditary disorder affecting the growth and development of the retinal vasculature, leading to vision impairment or blindness. The test is crucial for individuals with a family history of the disorder or those exhibiting symptoms, providing essential information for early intervention and management of the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the FZD4 gene and offering a pathway towards personalized treatment plans for affected individuals.
The NDP Gene Exudative Vitreoretinopathy Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the NDP gene, which are linked to the development of Exudative Vitreoretinopathy Type 2 (EVR2). This condition is a rare genetic disorder affecting the retina, leading to vision impairment or blindness. The test is crucial for early detection, enabling timely intervention and management of the condition to preserve vision and improve the quality of life for affected individuals.
The testing process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for any genetic abnormalities in the NDP gene. This test is particularly important for individuals with a family history of EVR2 or those showing symptoms related to vision problems, as it can confirm the diagnosis and guide treatment options.
The cost of the NDP Gene Exudative Vitreoretinopathy Type 2 Genetic Test at DNA Labs UAE is 4400 AED. While the price might seem high, the test offers invaluable insights into the genetic underpinnings of this condition, facilitating early and effective management strategies for those affected.
The TSPAN12 gene plays a crucial role in the development and maintenance of the vascular system in the retina. Mutations in the TSPAN12 gene can lead to a condition known as exudative vitreoretinopathy type 5 (EVR5), a rare genetic disorder that affects the retinal vasculature, leading to vision loss and blindness if not properly managed. This condition is characterized by abnormal blood vessel growth and fluid leakage in the retina, causing the layers of the retina to separate and resulting in severe visual impairment.
To diagnose this condition, a genetic test can be conducted to identify mutations in the TSPAN12 gene. DNA Labs UAE offers this specific genetic testing service, providing a crucial tool for the diagnosis and management of exudative vitreoretinopathy type 5. The test is priced at 4400 AED and is performed in their state-of-the-art facilities. By accurately identifying the genetic mutation, healthcare providers can better understand the prognosis of the disease and tailor treatment plans to manage symptoms and preserve vision, offering hope to affected individuals and their families.
The KIF21A gene plays a crucial role in the development and proper function of extraocular muscles, which are essential for eye movements. Mutations in this gene can lead to a condition known as congenital fibrosis of the extraocular muscles type 1 (CFEOM1), a rare genetic disorder characterized by restricted eye movements and droopy eyelids present from birth. This condition can significantly impact an individual's ability to move their eyes normally, often resulting in fixed downward gaze and crossed eyes, which may necessitate corrective surgery.
To diagnose this condition accurately, genetic testing of the KIF21A gene is recommended. DNA Labs UAE offers a comprehensive genetic test designed to identify mutations in the KIF21A gene that are associated with congenital fibrosis of the extraocular muscles type 1. This test is crucial for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding clinical management.
The cost of the KIF21A gene fibrosis of extraocular muscles congenital type 1 genetic test at DNA Labs UAE is 4400 AED. Conducted in a state-of-the-art facility, this test involves analyzing the patient's DNA sample to detect mutations in the KIF21A gene. The process is straightforward, requiring only a simple sample collection, after which the sample is processed and analyzed by experienced geneticists. Results from the test provide valuable information for patients and their families regarding the diagnosis, prognosis, and possible treatment options for CFEOM1.
The TUBB3 gene fibrosis of extraocular muscles congenital type 3a (FEOM3) genetic test is a specialized diagnostic tool used to identify mutations in the TUBB3 gene, which are associated with the development of FEOM3. This condition is a rare, inherited disorder characterized by the fibrosis of the extraocular muscles, leading to restricted eye movements and often strabismus (misalignment of the eyes). The test is crucial for confirming the diagnosis, understanding the genetic basis of the disorder, and guiding clinical management and genetic counseling for affected individuals and their families.
Performed at DNA Labs UAE, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the TUBB3 gene. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results accurately. By identifying the genetic underpinnings of FEOM3, this test plays a vital role in advancing our understanding of the condition and facilitating personalized treatment approaches for those affected.
The PAX6 Gene Coloboma of Optic Nerve Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PAX6 gene, which are associated with the development of coloboma of the optic nerve. Coloboma is a condition characterized by the incomplete closure of the optic nerve, leading to vision impairment and potentially blindness. The PAX6 gene plays a crucial role in eye development during the embryonic stage, and mutations in this gene can disrupt normal eye formation, resulting in various ocular anomalies including coloboma.
This genetic test involves analyzing the patient's DNA to detect any abnormalities in the PAX6 gene that might contribute to the condition. The process is non-invasive, requiring only a sample of blood or saliva from the patient. The test is particularly recommended for individuals with a family history of coloboma or related eye disorders, as well as for those exhibiting symptoms of the condition, to provide a definitive diagnosis and facilitate appropriate management and treatment plans.
The cost of the PAX6 Gene Coloboma of Optic Nerve Genetic Test at DNA Labs UAE is 4400 AED. This investment can provide critical insights into the genetic underpinnings of coloboma, allowing for targeted interventions and counseling for affected individuals and their families. It is a crucial step towards personalized medicine in the realm of ophthalmology, offering hope and solutions to those impacted by this challenging condition.
The "PAX6 Gene Coloboma Ocular Autosomal Dominant Genetic Test" is a specialized diagnostic assessment conducted to detect mutations in the PAX6 gene, which are linked to ocular coloboma—a condition characterized by missing pieces of tissue in structures that form the eye, leading to vision impairment or loss. This test is crucial for individuals showing symptoms of ocular coloboma or those with a family history of the condition, as it confirms the diagnosis and helps in understanding the risk of passing the genetic mutation to offspring. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for abnormalities in the PAX6 gene. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided, enabling targeted management and counseling for affected individuals and their families.
